This article first appeared on GuruFocus. Lineage Inc (NASDAQ:LINE) is set to release its Q3 2025 earnings on Nov 5, 2025.

Fintel reports that on November 6, 2025, Piper Sandler downgraded their outlook for Lineage (NasdaqGS:LINE) from Overweight ...

Enterprises that still view analytics as a reporting function will soon be outpaced by those that build decision intelligence ...

In the age of algorithmic intelligence, data is no longer just an asset — it is a self-regulating system whose health determines the stability and success of modern enterprises. To manage data ...

Cyberhaven expands its industry-leading data lineage and DLP capabilities with DSPM Early Access.

Lineage (LINE) posted continued losses, with net losses compounding at a rate of 47.2% per year over the past five years. Revenue is forecast to rise by 6.2% per year, while earnings are expected to ...

Get the latest on Lineage Cell Therapeutics' Q3 2025 earnings: clinical advances in OpRegen, new partnerships, and extended cash runway.

This article describes how vibe coding is lowering the barrier to entry and boosting developer productivity for startups and ...

Agentic AI systems promise to enhance human productivity by automating complex tasks through intelligent reasoning.

CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Lineage Cell Therapeutics, Inc. (LCTX) on Thursday reported a loss of $29.8 million in its third quarter. The Carlsbad, California-based company said it ...

Lineage (LINE) on Wednesday reported a key measure of profitability in its third quarter. The results exceeded Wall Street expectations.